Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,725,764
+$365,781 QoQ
Shares Held
10,832
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,716
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Obermeyer Wealth Partners holds $14,931,348 across 9 Drug Manufacturers - General names. ABBV ranks #2 (18.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,201 | $3,098,687 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
10,832 | $2,725,764 | |
| 3 | AZN |
Astrazeneca PLC
|
11,635 | $2,206,228 | |
| 4 | LLY |
ELI LILLY & Co
|
1,757 | $2,107,398 | |
| 5 | AMGN |
Amgen Inc
|
3,986 | $1,443,410 | |
| 6 | PFE |
Pfizer Inc
|
49,336 | $1,188,010 | |
| 7 | MRK |
Merck & Co., Inc.
|
8,359 | $1,074,131 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,532 | $722,093 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,725,764 | 10,832 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,359,983 | 10,851 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,423,364 | 10,606 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,431,633 | 10,502 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,190,872 | 11,803 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,988,461 | 23,809 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $4,121,218 | 23,192 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,693,073 | 18,701 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,162,142 | 18,436 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,291,093 | 18,073 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,620,986 | 10,460 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,541,280 | 10,340 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,336,656 | 9,921 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,631,470 | 10,237 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,820,375 | 11,264 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,547,978 | 11,534 | Shares | Sole | 2022-12-09 | |
| 2022-06-30 | $1,825,514 | 11,919 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,822,440 | 11,242 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,523,385 | 11,251 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,215,371 | 11,267 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,294,120 | 11,489 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,169,317 | 10,805 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $719,083 | 6,711 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $573,364 | 6,546 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $666,151 | 6,785 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $507,273 | 6,658 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||